Financhill
Sell
43

RVPH Quote, Financials, Valuation and Earnings

Last price:
$0.59
Seasonality move :
-0.35%
Day range:
$0.58 - $0.62
52-week range:
$0.25 - $2.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
15.14x
Volume:
4.5M
Avg. volume:
4.3M
1-year change:
-60.07%
Market cap:
$68.9M
Revenue:
--
EPS (TTM):
-$0.46

Earnings Data

Next earnings date for RVPH
Mar 30
2026
Most recent earnings per share
-$0.06
Beat by $0.04
(Nov 13/2025)
Consensus Estimate
-$0.10
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RVPH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/30/2026 Q4 -- -- -- -$0.06 --
11/13/2025 Q3 -- -- -$0.06 -$0.10 $0.04
08/14/2025 Q2 -- -- -$0.12 -$0.11 -$0.01
05/13/2025 Q1 -- -- -$0.13 -$0.18 $0.05
03/31/2025 Q4 -- -- -$0.15 -$0.22 $0.07
11/14/2024 Q3 -- -- -$0.25 -$0.25 $0.00
08/14/2024 Q2 -- -- -$0.26 -$0.31 $0.05
05/14/2024 Q1 -- -- -$0.25 -$0.38 $0.13
03/29/2024 Q4 -- -- -$0.35 -$0.37 $0.02
11/14/2023 Q3 -- -- -$0.48 -$0.39 -$0.09
08/14/2023 Q2 -- -- -$0.52 -- --
05/15/2023 Q1 -- -- -$0.31 -- --
03/30/2023 Q4 -- -- -$0.40 -- --
11/14/2022 Q3 -- -- -$0.18 -- --
08/15/2022 Q2 -- -- -$0.29 -- --
03/31/2022 Q1 -- -- -$0.40 -- --
12/31/2021 Q4 -- -- -$0.26 -- --
11/15/2021 Q3 -- -- -$0.12 -- --
08/16/2021 Q2 -- -- -$0.12 -- --
05/17/2021 Q1 -- -- -$0.10 -- --
12/31/2020 Q4 -- -- -$0.42 -- --
01/14/2021 Q4 -- -- -$0.04 -- --
09/30/2020 Q3 -- -- -$0.24 -- --
06/30/2020 Q2 -- -- -$0.31 -- --
03/31/2020 Q1 -- -- -$0.27 -- --
02/29/2020 Q1 -- -- -$0.02 -- --
11/30/2019 Q4 -- -- $0.05 -- --
08/31/2019 Q3 -- -- $0.11 -- --
05/31/2019 Q2 -- -- $0.13 -- --
02/28/2019 Q1 -- -- $0.04 -- --
11/30/2018 Q4 -- -- $0.10 -- --
08/31/2018 Q3 -- -- $0.01 -- --
05/31/2018 Q2 -- -- -$0.01 -- --

Reviva Pharmaceuticals Holdings, Inc. Earnings Questions

  • How Much did Reviva Pharmaceuticals Holdings, Inc. Generate in Revenue Last Quarter?

    Reviva Pharmaceuticals Holdings, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Reviva Pharmaceuticals Holdings, Inc. Beat Earnings Last Quarter?

    Reviva Pharmaceuticals Holdings, Inc. announced earnings per share of -$0.06 which represents a beat of analyst forecast a -$0.10 per share.

  • Is Reviva Pharmaceuticals Holdings, Inc. Profitable?

    Reviva Pharmaceuticals Holdings, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Reviva Pharmaceuticals Holdings, Inc. EPS Next Year?

    Reviva Pharmaceuticals Holdings, Inc.'s earnings are forecast to decrease from -$0.90 per share to -$0.99 per share next year representing a decrease of -63.44%.

  • When is Reviva Pharmaceuticals Holdings, Inc.'s Earnings Date?

    Reviva Pharmaceuticals Holdings, Inc.'s next earnings date is March 30, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock